Medicinal product name Relvar Ellipta
Pharmaceutical form Inhalation powder, pre-dispensed
Strength 92 μg/22 μg 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
EU/1/13/886/002 KZSN30: 1 × 30 Is available
Legal status Rx Prescription (Pr.)
KZS NHS Reimbursed medicines
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code R03AK10 Drugs for obstructive airway diseases

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(5553 containers)
Tamro, Recipe Plus, Berlin-Chemie/Menarini Baltic, Magnum Medical, Baltfarm "Vita-Farm", Euroaptieka, Medelens+, Oribalt Rīga N30: 1 × 30
(92 µg/22 µg)
Aluminium blister 46.00 
KZS*
EU/1/13/886/002  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. EU/1/13/886/002
Date of authorisation Nov 13, 2013
Marketing authorisation holder, country GlaxoSmithKline (Ireland) Limited, Ireland